Purchase Order 75F40121P00562
Award Date 9/14/21
Potential Completion Date 11/16/26
Potential Value $749K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Berwyn Heights, MD 20740, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This $438,600 firm fixed price purchase order was awarded by the Department of Health and Human Services Food and Drug Administration to Pacific Biosciences of California, Inc. to deliver a SEQUEL IIE SYSTEM long-read DNA/RNA sequencing machine. The solicitation sought quotes for a turnkey sequencing solution to detect pathogen variants, access previously inaccessible genomic regions, and advance genetic research at the FDA's Center for Biologics Evaluation and Research Division of Cell and Gene...
- The Department of Health and Human Services Food and Drug Administration awarded a $51,193.93 purchase order to Pacific Biosciences of California, Inc. for sequencing supplies. The firm fixed price contract runs from August 23, 2023 to February 19, 2024 and will be performed by Pacific Biosciences in West Menlo Park, California. The original solicitation sought sequencing supplies as described in Combined Synopsis Solicitation 75F40123Q-117934 to support the FDA's evaluation of new sequencing...
- This contract award to Pacific Biosciences of California, Inc., a small business manufacturer, is for the provision of high-throughput, long-read DNA sequencing systems and associated consumables to the U.S. Food and Drug Administration (FDA). The $83,644 firm fixed-price purchase order has an ultimate completion date of October 14, 2015. Pacific Biosciences is the original equipment manufacturer for their proprietary single molecule, real-time (SMRT) sequencing technology, which is utilized...
- The Food and Drug Administration awarded a $22.9K firm fixed-price purchase order to Pacific Biosciences of California, Inc., a Menlo Park-based biotechnology manufacturer specializing in advanced DNA and RNA sequencing technologies. The award, designated as a total small business set-aside, was executed on July 27, 2021, for SMRT cell 8M trays and Sequel II sequencing kits—consumable products essential for next-generation sequencing operations. The procurement was completed ahead of the October...
- Pacific Biosciences of California, Inc., a small business biotechnology firm specializing in long-read DNA and RNA sequencing technologies, received a $726,318.04 firm fixed-price purchase order from the Food and Drug Administration on September 28, 2023. The award covers a Sequel IIE long-read DNA/RNA sequencer system and associated consumables to support the National Antimicrobial Resistance Monitoring System. The contract, designated as a total small business set-aside, includes performance...
- The U.S. Food and Drug Administration awarded a $736,000 firm fixed-price definitive contract to Pacific Biosciences of California, Inc. for a real-time sequencer system with four one-year post-warranty maintenance option periods. The contract, awarded on September 3, 2019, with an ultimate completion date of December 11, 2024, is designated as a Total Small Business set-aside. Pacific Biosciences, a leading biotechnology company specializing in advanced DNA and RNA sequencing technologies, will...
- The Department of Health and Human Services Food and Drug Administration awarded a $534,031 firm fixed price purchase order to Illumina, Inc. of San Diego, California. The contract is for an Illumina NextSeq 2000 High Throughput Next-Generation Sequencing System to be delivered to Silver Spring, Maryland. The solicitation notice indicated the FDA requires this sequencing system to adapt standard operating procedures for its currently installed Illumina NextSeq 500 model, scale up sequencing...
- This is a delivery order awarded to Pacific Biosciences of California, Inc., a manufacturer of DNA/RNA sequencing systems and associated consumables, by the Department of Health and Human Services' Food and Drug Administration. The $69,567.00 firm-fixed-price order is for the provision of sequencing reagents, kits, and consumables to support the agency's genomic research initiatives. Pacific Biosciences has extensive experience providing specialized sequencing equipment and supplies to various...
- This is a $505,454 firm-fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Pacific Biosciences of California, Inc., a small business manufacturer of advanced DNA sequencing systems and reagents. The contract is for the delivery of a "REAL TIME DNA SEQUENCER" and is set aside for small business. Pacific Biosciences specializes in their proprietary single molecule, real-time (SMRT) sequencing technology, which is utilized by various federal...
- The Department of Health and Human Services Food and Drug Administration awarded a $406,184 firm fixed price purchase order contract to Pacific Biosciences of California, Inc. for the provision of DNA sequencer and cluster generator hardware and software, as well as four annual preventative maintenance agreements to be exercised annually. The place of performance will be Laurel, Maryland and the period of performance is from September 26, 2023 through October 26, 2028. The contract was set aside...